Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
43.81
-0.98 (-2.19%)
At close: Jul 7, 2025, 4:00 PM
44.32
+0.51 (1.16%)
After-hours: Jul 7, 2025, 7:03 PM EDT

Kymera Therapeutics Market Cap

Kymera Therapeutics has a market cap or net worth of $3.07 billion as of July 7, 2025. Its market cap has increased by 60.57% in one year.

Market Cap
3.07B
Enterprise Value
2.38B
1-Year Change
60.57%
Ranking
Category
Stock Price
$43.81

Market Cap Chart

Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $3.07B, an increase of 268.36%. That is a compound annual growth rate of 30.63%.

History

DateMarket Cap% Change
Jul 7, 20253.07B17.98%
Dec 31, 20242.61B84.43%
Dec 29, 20231.41B3.16%
Dec 30, 20221.37B-57.98%
Dec 31, 20213.26B18.59%
Dec 31, 20202.75B229.33%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 700.84B
Johnson & Johnson 375.37B
AbbVie 334.34B
Novo Nordisk 316.33B
UnitedHealth Group 279.90B
Novartis AG 242.35B
Abbott Laboratories 233.90B
AstraZeneca 218.65B
Market Cap Rankings